-
公开(公告)号:US07235243B2
公开(公告)日:2007-06-26
申请号:US11173364
申请日:2005-07-01
申请人: Robert S. Becker , Robert C. Huebner , Maryann Gray , Karen S. Biscardi , Lorne F. Erdile , Bruno Guy
发明人: Robert S. Becker , Robert C. Huebner , Maryann Gray , Karen S. Biscardi , Lorne F. Erdile , Bruno Guy
IPC分类号: A61K39/00
CPC分类号: A61K39/0225 , A61K39/092 , A61K39/105 , A61K39/12 , A61K39/145 , A61K39/39 , A61K2039/5252 , A61K2039/542 , A61K2039/543 , A61K2039/55505 , A61K2039/55516 , A61K2039/55544 , A61K2039/6018 , A61K2039/70 , C07K14/20 , C07K14/285 , C07K14/3156 , C12N2760/16134 , Y02A50/401 , Y10S424/828 , A61K39/102 , A61K39/09 , A61K2300/00
摘要: Immununological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.
摘要翻译: 免疫学组成和制备和使用它们的方法。 组合物含有至少一种抗原和至少一种脂蛋白和任选的佐剂。 脂蛋白本身可以是抗原性的或免疫原性的。 抗原可以是流感HA,脂蛋白是具有用于脂质化的OspA前导物和蛋白质部分的PspA的重组表达产物。 抗原可以是OspC和脂蛋白OspA。 组合物的组分共同施用。 通过组合物和方法获得增强的免疫应答。
-
公开(公告)号:US06984385B2
公开(公告)日:2006-01-10
申请号:US10096687
申请日:2002-03-12
申请人: Robert S. Becker , Robert C. Huebner , Maryann Gray , Karen S. Biscardi , Lorne F. Erdile , Bruno Guy
发明人: Robert S. Becker , Robert C. Huebner , Maryann Gray , Karen S. Biscardi , Lorne F. Erdile , Bruno Guy
IPC分类号: A61K39/00
CPC分类号: A61K39/0225 , A61K39/092 , A61K39/105 , A61K39/12 , A61K39/145 , A61K39/39 , A61K2039/5252 , A61K2039/542 , A61K2039/543 , A61K2039/55505 , A61K2039/55516 , A61K2039/55544 , A61K2039/6018 , A61K2039/70 , C07K14/20 , C07K14/285 , C07K14/3156 , C12N2760/16134 , Y02A50/401 , Y10S424/828 , A61K39/102 , A61K39/09 , A61K2300/00
摘要: Immunological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.
-
公开(公告)号:US06379675B1
公开(公告)日:2002-04-30
申请号:US08588621
申请日:1996-01-19
申请人: Robert S. Becker , Robert C. Huebner , Maryann Gray , Karen S. Biscardi , Lorne F. Erdile , Bruno Guy
发明人: Robert S. Becker , Robert C. Huebner , Maryann Gray , Karen S. Biscardi , Lorne F. Erdile , Bruno Guy
IPC分类号: A61K3902
CPC分类号: A61K39/0225 , A61K39/092 , A61K39/105 , A61K39/12 , A61K39/145 , A61K39/39 , A61K2039/5252 , A61K2039/542 , A61K2039/543 , A61K2039/55505 , A61K2039/55516 , A61K2039/55544 , A61K2039/6018 , A61K2039/70 , C07K14/20 , C07K14/285 , C07K14/3156 , C12N2760/16134 , Y02A50/401 , Y10S424/828 , A61K39/102 , A61K39/09 , A61K2300/00
摘要: Immunological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.
-
公开(公告)号:US06538118B1
公开(公告)日:2003-03-25
申请号:US09067453
申请日:1998-04-28
申请人: Robert C. Huebner , Lorne F. Erdile , Donald J. Warakomski, Jr. , Robert S. Becker , Maryann B. Gray , Derek J. Pyle
发明人: Robert C. Huebner , Lorne F. Erdile , Donald J. Warakomski, Jr. , Robert S. Becker , Maryann B. Gray , Derek J. Pyle
IPC分类号: C07H2104
CPC分类号: C07K14/315 , A61K38/00 , C07K14/195 , C07K14/205 , C07K2319/02 , C07K2319/40 , C12N15/625 , C12P21/02 , Y02A50/401
摘要: Heterologous lipidated proteins formed recombinantly are disclosed and claimed. The expression system can be E. coli. The heterologous lipidated protein has a leader sequence which does not naturally occur with the protein portion of the lipidated protein. The lipidated protein can have the Borrelia OspA leader sequence. The protein portion can be OspC, PspA, UreA, Ure B, or a fragment thereof. Methods and compositions for forming and employing the proteins are also disclosed and claimed.
摘要翻译: 公开并要求重组形成的异源脂质化蛋白。 表达系统可以是大肠杆菌。 异源脂质化蛋白质具有不与脂质化蛋白质的蛋白质部分天然存在的前导序列。 脂质化蛋白可以具有疏螺旋体OspA前导序列。 蛋白质部分可以是OspC,PspA,UreA,Ure B或其片段。 用于形成和应用蛋白质的方法和组合物也被公开和要求保护。
-
公开(公告)号:US20140113371A1
公开(公告)日:2014-04-24
申请号:US13888024
申请日:2013-05-06
申请人: David Berd , Lorne F. Erdile , Margalit B. Mokyr
发明人: David Berd , Lorne F. Erdile , Margalit B. Mokyr
IPC分类号: A01N1/02
CPC分类号: A01N1/0221 , A01N1/02
摘要: A method of preserving haptenized tumor cells is described. The method employs a freezing medium containing an effective amount of sucrose and human serum albumin in an isotonic buffered saline solution. Cryogenically preserving haptenized cells in such a medium has been found to maintain the integrity of the tumor cells during storage. The haptenized tumor cells also retain cell-associated antigens and haptens, and are as immunogenic, i.e., capable of inducing immunotherapeutic response, as fresh vaccine in a mouse model of metastatic disease. In a specific embodiment, haptenized cells are exposed to a solution of 8% sucrose, 10% human serum albumin in Hank's buffered solution, and then frozen to −80° C. overnight and then stored in a liquid nitrogen freezer. Methods of storing haptenized tumor cells and compositions are also provided.
摘要翻译: 描述了保留半抗原的肿瘤细胞的方法。 该方法在等渗缓冲盐水溶液中使用含有有效量的蔗糖和人血清白蛋白的冷冻介质。 已经发现在这种培养基中低温保存半抗原细胞在保存期间维持肿瘤细胞的完整性。 半抗原的肿瘤细胞还保留细胞相关抗原和半抗原,并且作为免疫原性,即能够诱导免疫治疗应答,作为转移性疾病的小鼠模型中的新鲜疫苗。 在一个具体实施方案中,将半抗原细胞暴露于Hank's缓冲溶液中的8%蔗糖,10%人血清白蛋白的溶液中,然后冷冻至-80℃过夜,然后储存在液氮冷冻器中。 还提供了存储半抗原化肿瘤细胞和组合物的方法。
-
公开(公告)号:US08435784B2
公开(公告)日:2013-05-07
申请号:US11762409
申请日:2007-06-13
申请人: David Berd , Lorne F. Erdile , Margalit B. Mokyr
发明人: David Berd , Lorne F. Erdile , Margalit B. Mokyr
CPC分类号: A01N1/0221 , A01N1/02
摘要: A method of preserving haptenized tumor cells is described. The method employs a freezing medium containing an effective amount of sucrose and human serum albumin in an isotonic buffered saline solution. Cryogenically preserving haptenized cells in such a medium has been found to maintain the integrity of the tumor cells during storage. The haptenized tumor cells also retain cell-associated antigens and haptens, and are as immunogenic, i.e., capable of inducing immunotherapeutic response, as fresh vaccine in a mouse model of metastatic disease. In a specific embodiment, haptenized cells are exposed to a solution of 8% sucrose, 10% human serum albumin in Hank's buffered solution, and then frozen to −80° C. overnight and then stored in a liquid nitrogen freezer. Methods of storing haptenized tumor cells and compositions are also provided.
摘要翻译: 描述了保留半抗原的肿瘤细胞的方法。 该方法在等渗缓冲盐水溶液中使用含有有效量的蔗糖和人血清白蛋白的冷冻介质。 已经发现在这种培养基中低温保存半抗原细胞在保存期间维持肿瘤细胞的完整性。 半抗原的肿瘤细胞还保留细胞相关抗原和半抗原,并且作为免疫原性,即能够诱导免疫治疗应答,作为转移性疾病的小鼠模型中的新鲜疫苗。 在一个具体实施方案中,将半抗原细胞暴露于Hank's缓冲溶液中的8%蔗糖,10%人血清白蛋白的溶液中,然后冷冻至-80℃过夜,然后储存在液氮冷冻器中。 还提供了存储半抗原化肿瘤细胞和组合物的方法。
-
-
-
-
-